비PVC IV 백 시장(2025-2029년)

The global non-pvc iv bags market is forecasted to grow by USD 714.7 mn during 2024-2029, accelerating at a CAGR of 6.3% during the forecast period. The report on the global non-pvc iv bags market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by regulatory and clinical focus on patient safety, increasing environmental concerns, increase number of hospitals and medical facilities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global non-pvc iv bags market is segmented as below:

By Product

• Single chamber
• Multi chamber

By Material Type

• Ethylene vinyl acetate
• Polypropylene
• Copolyester ether

By Application

• Chemotherapy
• Electrolyte and glucose infusion
• Parenteral nutrition

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of smart technology and sustainability as one of the prime reasons driving the global non-pvc iv bags market growth during the next few years. Also, increasing product launches by key players and healthcare infrastructure growth will lead to sizable demand in the market.

The report on the global non-pvc iv bags market covers the following areas:

• Global non-pvc iv bags market sizing
• Global non-pvc iv bags market forecast
• Global non-pvc iv bags market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global non-pvc iv bags market vendors that include ANGIPLAST Pvt. Ltd., B.Braun SE, Baxter International Inc., Fresenius SE and Co. KGaA, Haemotronic Spa, ICU Medical Inc., JW Life Science Corp., Medline Industries LP, Ningbo Siny Medical Technology, Otsuka Holdings Co. Ltd., POLYCINE GmbH, RENOLIT SE, Rusoma Laboratories Pvt. Ltd., Sartorius AG, Shanghai IVEN Pharmatech, Silica Healthcare Pvt. Ltd., Spirit Medical Ltd., SSY Group Ltd., Taj Pharmaceuticals Ltd., Technoflex. Also, the global non-pvc iv bags market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Material Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Non-PVC IV Bags Market 2019 - 2023
  • Historic Market Size - Data Table on Global Non-PVC IV Bags Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 Material Type segment analysis 2019 - 2023
  • Historic Market Size - Material Type Segment 2019 - 2023 ($ million)
• 5.4 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The Impact of AI on the Global Non-PVC IV Bags Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Single chamber - Market size and forecast 2024-2029
• 8.4 Multi chamber - Market size and forecast 2024-2029
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Material Type

• 9.1 Market segments
• 9.2 Comparison by Material Type
• 9.3 Ethylene vinyl acetate - Market size and forecast 2024-2029
• 9.4 Polypropylene - Market size and forecast 2024-2029
• 9.5 Copolyester ether - Market size and forecast 2024-2029
• 9.6 Market opportunity by Material Type
  • Market opportunity by Market Segmentation by Material Type ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Chemotherapy - Market size and forecast 2024-2029
• 10.4 Electrolyte and glucose infusion - Market size and forecast 2024-2029
• 10.5 Parenteral nutrition - Market size and forecast 2024-2029
• 10.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Asia - Market size and forecast 2024-2029
  • 12.4.1 China - Market size and forecast 2024-2029
  • 12.4.2 Japan - Market size and forecast 2024-2029
  • 12.4.3 India - Market size and forecast 2024-2029
  • 12.4.4 South Korea - Market size and forecast 2024-2029
  • 12.4.5 Indonesia - Market size and forecast 2024-2029
  • 12.4.6 Thailand - Market size and forecast 2024-2029
• 12.5 Europe - Market size and forecast 2024-2029
  • 12.5.1 Germany - Market size and forecast 2024-2029
  • 12.5.2 UK - Market size and forecast 2024-2029
  • 12.5.3 France - Market size and forecast 2024-2029
  • 12.5.4 Italy - Market size and forecast 2024-2029
  • 12.5.5 Spain - Market size and forecast 2024-2029
  • 12.5.6 The Netherlands - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Brazil - Market size and forecast 2024-2029
  • 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.3 UAE - Market size and forecast 2024-2029
  • 12.6.4 Turkey - Market size and forecast 2024-2029
  • 12.6.5 Argentina - Market size and forecast 2024-2029
  • 12.6.6 Colombia - Market size and forecast 2024-2029
  • 12.6.7 South Africa - Market size and forecast 2024-2029
  • 12.6.8 Israel - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Regulatory and clinical focus on patient safety
  • Increasing environmental concerns
  • Increase number of hospitals and medical facilities
• 13.2 Market challenges
  • High costs and regulatory barriers
  • Availability of counterfeit products
  • Material compatibility and drug stability
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Integration of smart technology and sustainability
  • Increasing product launches by key players
  • Healthcare infrastructure growth

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 ANGIPLAST Pvt. Ltd.
  • ANGIPLAST Pvt. Ltd. - Overview
  • ANGIPLAST Pvt. Ltd. - Product / Service
  • ANGIPLAST Pvt. Ltd. - Key offerings
  • SWOT
• 15.5 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • SWOT
• 15.6 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.7 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key news
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
  • SWOT
• 15.8 Haemotronic Spa
  • Haemotronic Spa - Overview
  • Haemotronic Spa - Product / Service
  • Haemotronic Spa - Key offerings
  • SWOT
• 15.9 ICU Medical Inc.
  • ICU Medical Inc. - Overview
  • ICU Medical Inc. - Product / Service
  • ICU Medical Inc. - Key offerings
  • SWOT
• 15.10 JW Life Science Corp.
  • JW Life Science Corp. - Overview
  • JW Life Science Corp. - Product / Service
  • JW Life Science Corp. - Key offerings
  • SWOT
• 15.11 Medline Industries LP
  • Medline Industries LP - Overview
  • Medline Industries LP - Product / Service
  • Medline Industries LP - Key offerings
  • SWOT
• 15.12 Ningbo Siny Medical Technology
  • Ningbo Siny Medical Technology - Overview
  • Ningbo Siny Medical Technology - Product / Service
  • Ningbo Siny Medical Technology - Key offerings
  • SWOT
• 15.13 Otsuka Holdings Co. Ltd.
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key news
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Segment focus
  • SWOT
• 15.14 POLYCINE GmbH
  • POLYCINE GmbH - Overview
  • POLYCINE GmbH - Product / Service
  • POLYCINE GmbH - Key offerings
  • SWOT
• 15.15 RENOLIT SE
  • RENOLIT SE - Overview
  • RENOLIT SE - Product / Service
  • RENOLIT SE - Key offerings
  • SWOT
• 15.16 Rusoma Laboratories Pvt. Ltd.
  • Rusoma Laboratories Pvt. Ltd. - Overview
  • Rusoma Laboratories Pvt. Ltd. - Product / Service
  • Rusoma Laboratories Pvt. Ltd. - Key offerings
  • SWOT
• 15.17 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key news
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.18 Shanghai IVEN Pharmatech
  • Shanghai IVEN Pharmatech - Overview
  • Shanghai IVEN Pharmatech - Product / Service
  • Shanghai IVEN Pharmatech - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations